Literature DB >> 8696988

Alterations in coagulation and fibrinolysis during sepsis.

A Kidokoro1, T Iba, M Fukunaga, Y Yagi.   

Abstract

Circulating levels of thrombin-antithrombin III complex (TAT) and plasmin-alpha 2 plasmin inhibitor complex (PIC) in 49 septic patients (23 patients with organ dysfunction (OD), 26 without OD) and 11 postgastrectomy patients were measured to determine the significance of the coagulation-fibrinolytic systems in the development of OD. Tissue plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1), and thrombomodulin were also measured. The mean level of TAT on the day when OD occurred was significantly higher compared with the maximum level of TAT in septic patients without OD (P < .01) or postoperative patients (P < .01). There was no difference in PIC levels between the three groups. The TAT/PIC ratio was significantly higher in septic patients with OD compared with the other groups (P < .001). Septic patients with OD showed higher levels of PAI-1 (P < .001) but not of t-PA. Thrombomodulin levels were significantly higher in the septic patients with OD compared with the others (P < .001). We conclude that suppression of the fibrinolytic system contributes to the imbalance between coagulation and fibrinolysis, and that this hypercoagulable millieu on the endothelial surface leads to the onset of OD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696988     DOI: 10.1097/00024382-199603000-00010

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  14 in total

Review 1.  Emerging therapies in severe sepsis.

Authors:  S J Finney; T W Evans
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome.

Authors:  Francesco Imperatore; Salvatore Cuzzocrea; Domenico De Lucia; Marcella Sessa; Barbara Rinaldi; Annalisa Capuano; Giovanni Liguori; Amelia Filippelli; Francesco Rossi
Journal:  Intensive Care Med       Date:  2006-09-15       Impact factor: 17.440

Review 3.  Anticoagulant modulation of inflammation in severe sepsis.

Authors:  Karen S Allen; Eva Sawheny; Gary T Kinasewitz
Journal:  World J Crit Care Med       Date:  2015-05-04

4.  A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC.

Authors:  Toshiaki Iba; Marcello Di Nisio; Jecko Thachil; Hideo Wada; Hidesaku Asakura; Koichi Sato; Daizoh Saitoh
Journal:  Clin Appl Thromb Hemost       Date:  2017-07-27       Impact factor: 2.389

5.  Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.

Authors:  Jean-François Dhainaut; Pierre-François Laterre; Jonathan M Janes; Gordon R Bernard; Antonio Artigas; Jan Bakker; Hanno Riess; Bruce R Basson; Julien Charpentier; Barbara G Utterback; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

6.  Drotrecogin alfa (activated).

Authors:  Katherine A Lyseng-Williamson; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Biomarkers of endothelial cell activation in early sepsis.

Authors:  Simon Skibsted; Alan E Jones; Michael A Puskarich; Ryan Arnold; Robert Sherwin; Stephen Trzeciak; Philipp Schuetz; William C Aird; Nathan I Shapiro
Journal:  Shock       Date:  2013-05       Impact factor: 3.454

8.  Assessment of clinical outcome of children with sepsis outside the intensive care unit.

Authors:  Federica Zallocco; Patrizia Osimani; Ines Carloni; Vittorio Romagnoli; Silvia Angeloni; Salvatore Cazzato
Journal:  Eur J Pediatr       Date:  2018-09-17       Impact factor: 3.183

9.  The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis.

Authors:  Nathan I Shapiro; Philipp Schuetz; Kiichiro Yano; Midori Sorasaki; Samir M Parikh; Alan E Jones; Stephen Trzeciak; Long Ngo; William C Aird
Journal:  Crit Care       Date:  2010-10-13       Impact factor: 9.097

10.  Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.

Authors:  M Hoshino; Y Haraguchi; H Hirasawa; M Sakai; H Saegusa; K Hayashi; N Horita; H Ohsawa
Journal:  Crit Care       Date:  2001-02-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.